Marianne Romeo
Corporate Officer/Principal chez MYOVANT SCIENCES LTD.
Postes actifs de Marianne Romeo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MYOVANT SCIENCES LTD. | Corporate Officer/Principal | - | - |
| Bermuda Society For Healthcare Risk Management | Directeur/Membre du Conseil | - | - |
Historique de carrière de Marianne Romeo
Anciens postes connus de Marianne Romeo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | - | 01/04/2023 |
| Bowring Marsh (Bermuda) Ltd. | Directeur Général | 01/01/2003 | 01/01/2014 |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/03/2014 | - |
| SIO GENE THERAPIES INC. | Directeur/Membre du Conseil | 01/03/2015 | - |
| Corporate Officer/Principal | 01/03/2015 | - |
Formation de Marianne Romeo
| Tufts University | Undergraduate Degree |
| Hunter College | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Bermudes | 3 |
| Royaume-Uni | 3 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
| Bermuda Society For Healthcare Risk Management | |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
| Bowring Marsh (Bermuda) Ltd. | |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Marianne Romeo
- Expérience
